Stay updated on OPUS Clinical Trial: Natalizumab in Focal Epilepsy

Sign up to get notified when there's something new on the OPUS Clinical Trial: Natalizumab in Focal Epilepsy page.
Latest website image capture
Clouds background image

Latest updates to the OPUS Clinical Trial: Natalizumab in Focal Epilepsy page

  1. Check
    2 days ago
    Change Detected
    Summary
    The site footer revision identifier changed from `v3.7.0` to `v3.7.1` on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-12T16:28:35.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the previous detailed study record content with a minimal access-restricted screen.
    Difference
    18%
    Check dated 2026-09-21T21:00:08.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.6, replacing Revision: v3.6.5. This is a metadata update indicating the page version rather than any substantive content change.
    Difference
    0.0%
    Check dated 2026-08-31T17:16:26.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    A '2017 ( U.S. NIH Grant/Contract )' entry was added to the study's identifiers, indicating NIH funding and placing it among the other study IDs.
    Difference
    0.0%
    Check dated 2026-08-24T17:14:58.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.4 to v3.6.5. This signals a newer version of the page rather than a content change.
    Difference
    0.0%
    Check dated 2026-08-10T10:48:00.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    The revision tag at the bottom of the page was updated to v3.6.4, indicating a newer version of the study record.
    Difference
    0.0%
    Check dated 2026-07-27T06:28:26.000Z thumbnail image

Stay in the know with updates to OPUS Clinical Trial: Natalizumab in Focal Epilepsy

Enter your email address, and we'll notify you when there's something new on the OPUS Clinical Trial: Natalizumab in Focal Epilepsy page.